(Q34462090)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Peptide vaccines against hepatitis B virus: from animal model to human studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

O B Engler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

W J Dai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Sette

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

I P Hunziker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Reichen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Cerny

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

457-465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

The optimization of helper T lymphocyte (HTL) function in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Induction in vitro of a primary human antiviral cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

CD4-independent in vivo priming of murine CTL by optimal MHC class I-restricted peptides derived from intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Virosomes as carriers for combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Interleukin-18 regulates both Th1 and Th2 responses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Immunoprophylactic strategies against respiratory influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900081-5

7 January 2021

10.1016/S0161-5890(01)00081-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741695%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference